Liz Holliday

Professor Liz Holliday is a Professor of Biostatistics at the University of Newcastle, serving as Deputy Head of School (Research) and Head of Discipline (Medical Statistics) within the School of Medicine and Public Health. She holds affiliations with the Data Sciences Support Unit at the Hunter Medical Research Institute. Her expertise spans biostatistics, epidemiology, and clinical trial design, with a focus on medical research excellence. Holliday has a BSc (Hons I) in Mathematics and Molecular Bioscience (2003), a PhD in Genetic Statistics (2008), and a Master of Science in Statistics (2012).

• Education:
  • Bachelor of Science (Honours), University of Queensland
  • PhD in Genetic Statistics, University of Queensland
  • Master of Science in Statistics, University of Queensland

Research Interests: Liz specializes in biostatistics and epidemiology, particularly in randomized controlled trials (fixed/adaptive designs), causal inference for observational studies, life expectancy estimation, generalized linear modeling, and genetic statistics. Her work emphasizes applications in health and medicine, including collaborations on stroke, respiratory diseases, and public health initiatives.

Publications & Awards: Co-author of over 340 peer-reviewed articles and six book chapters, Holliday has secured $30 million in research funding. Notable awards include the Star Graduate (2013), Career Development Award (2013), and Young Investigator Travel Award (2011). Her research has advanced statistical methods in medical studies and public health policy.

Grants & Collaborations: Holliday leads or collaborates on grants totaling $30 million, focusing on clinical trials, genetic studies, and public health interventions. She advises academic committees and government/industry bodies, emphasizing interdisciplinary research.

Labs & Teams: Affiliated with the Data Sciences Support Unit at HMRI, she collaborates with clinical and public health researchers globally, contributing to projects like the Stroke Genetics Consortium and respiratory disease studies.